PMID- 32440494 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231111 IS - 2214-031X (Print) IS - 2214-0328 (Electronic) IS - 2214-031X (Linking) VI - 22 DP - 2020 May TI - The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review. PG - 7-13 LID - 10.1016/j.jot.2019.08.004 [doi] AB - OBJECTIVE: The objective of this study was to assess the efficacy and safety of denosumab therapy in osteoporotic postmenopausal women who were previously treated with bisphosphonates. METHODS: Meta-analyses of four available randomised controlled trials that compared osteoporotic patients who switched to denosumab from bisphosphonates (n ​= ​1416) and those who continued bisphosphonates therapy (n ​= ​1411) were included. RESULTS: The increase in bone mineral density (BMD) of both the spine and hip was significantly higher in patients who shifted to denosumab than in those who continued bisphosphonates. Despite the incidence of adverse events (AEs) and fractures being comparable, treatment withdrawal owing to AEs was significantly less frequent in the denosumab group. CONCLUSION: The outcomes and treatment compliance were improved in postmenopausal osteoporotic women who shifted to denosumab from bisphosphonates. THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE: The replacement of bisphosphonates with denosumab may lead to better therapeutic efficacy and fewer adherence barriers ​than those with continued usage of bisphosphonates, which in the future may guide the choice of drug therapy in clinics. CI - (c) 2019 The Authors. FAU - Zhu, Yilin AU - Zhu Y AD - Department of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. FAU - Huang, Zhonglian AU - Huang Z AD - Department of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. FAU - Wang, Yan AU - Wang Y AD - Department of Orthopaedics and Traumatology, Beijing Jishuitan Hospital, Beijing, 100035, China. FAU - Xu, Weicai AU - Xu W AD - Department of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. FAU - Chen, Hongjiang AU - Chen H AD - Department of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. FAU - Xu, Jiankun AU - Xu J AD - Department of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. AD - Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, China. FAU - Luo, Shaowei AU - Luo S AD - Department of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. FAU - Zhang, Yuantao AU - Zhang Y AD - Department of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. FAU - Zhao, Di AU - Zhao D AD - Department of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. FAU - Hu, Jun AU - Hu J AD - Department of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. LA - eng PT - Journal Article PT - Review DEP - 20190909 PL - Singapore TA - J Orthop Translat JT - Journal of orthopaedic translation JID - 101625127 PMC - PMC7231967 OTO - NOTNLM OT - Bisphosphonate OT - Denosumab OT - Meta-analysis OT - Osteoporosis OT - Postmenopausal osteoporosis OT - Randomised controlled trial EDAT- 2020/05/23 06:00 MHDA- 2020/05/23 06:01 PMCR- 2019/09/09 CRDT- 2020/05/23 06:00 PHST- 2019/04/07 00:00 [received] PHST- 2019/07/31 00:00 [revised] PHST- 2019/08/12 00:00 [accepted] PHST- 2020/05/23 06:00 [entrez] PHST- 2020/05/23 06:00 [pubmed] PHST- 2020/05/23 06:01 [medline] PHST- 2019/09/09 00:00 [pmc-release] AID - S2214-031X(19)30200-1 [pii] AID - 10.1016/j.jot.2019.08.004 [doi] PST - epublish SO - J Orthop Translat. 2019 Sep 9;22:7-13. doi: 10.1016/j.jot.2019.08.004. eCollection 2020 May.